文献速递心脑血管急症消化、代谢与肾脏急症

老年非特异性主诉患者的肌钙蛋白检测与急性冠脉综合征:是否存在过度检测?

Troponin Testing and Coronary Syndrome in Geriatric Patients With Nonspecific Complaints: Are We Overtesting?
PubMed 文献 · Acad Emerg Med · 2019-12-19
一句话结论在急诊科以非特异性主诉就诊的老年患者中,急性冠脉综合征罕见(1.2%),肌钙蛋白升高者93.8%为假阳性,作者认为结果可能不支持对该人群常规检测肌钙蛋白。

该回顾性研究纳入2017年1月1日至6月30日急诊分诊为非特异性主诉(如乏力、头晕、疲劳)的≥65岁患者,排除局灶性主诉、发热或未查肌钙蛋白者,最终412例(69%接受了肌钙蛋白检测)组成研究队列。平均年龄78.7岁,58%女性,75%住院。肌钙蛋白升高81例(20%),30天内急性冠脉综合征(ACS)仅5例(1.2%)。肌钙蛋白诊断ACS的敏感性100%(95%CI 48%–100%),特异性81%(95%CI 77%–85%);肌钙蛋白升高者中93.8%为假阳性。所有肌钙蛋白升高者均住院,但仅1例接受血管造影,无患者接受再灌注治疗。作者结论认为该人群ACS罕见且无再灌注治疗,假阳性率高,结果可能不支持常规肌钙蛋白检测。

要点

  • 急诊老年非特异性主诉患者中,30天内ACS发生率仅1.2%(5/412),肌钙蛋白升高者20%(81/412)。
  • 肌钙蛋白诊断ACS敏感性100%(95%CI 48%–100%),特异性81%(95%CI 77%–85%)。
  • 肌钙蛋白升高患者中93.8%为假阳性(无ACS)。
  • 所有肌钙蛋白升高者均住院,但仅1例接受血管造影,无患者接受再灌注治疗。
  • 作者认为,鉴于假阳性率,结果可能不支持对该人群常规检测肌钙蛋白以诊断ACS。

适用人群与场景

  • 年龄≥65岁、急诊分诊为非特异性主诉(如乏力、头晕、疲劳)的患者。
  • 排除标准:提供者记录中有局灶性主诉、发热、未开具肌钙蛋白检测。

诊断标准与关键阈值

  • 非特异性主诉预先定义,包括乏力、头晕、疲劳等主诉,并由对检测结果盲法的 trained abstractors 在急诊提供者记录中核实。
  • ACS采用严格定义,由两名对研究假设盲法的 trained physician researchers 独立裁定。

研究设计与关键结果

  • 回顾性研究,筛查1146次就诊,排除552例(发热或局灶性主诉),剩余594例中412例(69%)开具肌钙蛋白,构成研究队列。
  • 平均年龄78.7(±8.3)岁,58%女性,75%住院。
  • 肌钙蛋白升高81例(20%);30天内ACS 5例(1.2%)。
  • 肌钙蛋白诊断ACS:敏感性100%(95%CI 48%–100%),特异性81%(95%CI 77%–85%)。
  • 肌钙蛋白升高患者中93.8%为假阳性(无ACS)。
  • 所有肌钙蛋白升高者均住院,但仅1例接受血管造影,无患者接受再灌注治疗。

证据类型、等级与局限

  • 研究类型:回顾性研究,样本量412例,单中心未报告。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在选定的老年非特异性主诉患者中考虑ACS是审慎的,但ACS罕见且无患者接受再灌注治疗。
  • 作者认为,鉴于本研究的假阳性率,结果可能不支持对该人群常规检测肌钙蛋白以诊断ACS。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Elderly patients presenting to the emergency department (ED) with nonspecific complaints (NSCs) often undergo troponin testing to assess for atypical acute coronary syndrome (ACS). However, the rate of ACS and utility of troponin testing in this population is unknown. We sought to determine the rate of ACS and diagnostic yield of troponin testing in elderly patients with NSCs.

METHODS: We retrospectively identified all patients aged ≥ 65 years triaged in the ED with NSCs from January 1, 2017, to June 30, 2017. NSCs were defined a priori and included complaints such as weakness, dizziness, or fatigue. NSCs were verified in ED provider notes by trained abstractors blind to testing results. Exclusions were focal chief complaint in provider notes, fever, and no troponin ordered. ACS was strictly defined and independently adjudicated by two trained physician researchers blind to the study hypothesis. We calculated the proportion of patients with ACS within 30 days and the test characteristics of troponin to diagnose ACS.

RESULTS: Screening identified 1,146 encounters, and 552 were excluded for fever or focal chief complaints in the provider notes. Of the remaining 594 patients, troponin was ordered in 412 (69%), comprising the study cohort. The mean (±SD) age was 78.7 (±8.3) years, with 58% female and 75% admitted. Troponin elevation occurred in 81 patients (20%). ACS occurred in 5 of 412 (1.2%). Troponin was 100% sensitive (95% confidence interval [CI] = 48% to 100%) and 81% specific (95% CI = 77% to 85%) for ACS. Of patients with elevated troponin, 93.8% were false positives (no ACS). All patients with troponin elevation were admitted, but only one underwent angiography and no patients received reperfusion therapy.

CONCLUSIONS: While consideration for ACS is prudent in selected elderly patients with NSCs, ACS was rare and no patients received reperfusion therapy. Given the false-positive rate in our study, our results may not support routine troponin testing for ACS in this population.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Wang AZ, Schaffer JT, Holt DB, et al. Troponin Testing and Coronary Syndrome in Geriatric Patients With Nonspecific Complaints: Are We Overtesting? Acad Emerg Med. 2019. PMID: 31854117. doi:10.1111/acem.13766

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。